RE:RE:RE:RE:RE:ONCY's pelareorep activates TiLs (CD8+ Dendritic Cells) Should read: Bracelet-1 - 12 month Phase 2 mOS data" ... showed a statistically significant near doubling of median overall survival in HR+/HER2- metastatic breast cancer patients treated with pelareorep combined with paclitaxel " compared to paclitaxel alone.